XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Reconciliation of cash and cash equivalents and restricted cash presented on the consolidated statements of cash flows    
Cash and cash equivalents $ 20,335 [1] $ 30,561
Restricted cash 27,954 [1] 125,708
Total cash and cash equivalents and restricted cash 48,289 156,269
Supplemental disclosure of non-cash investing and financing activity:    
Debt obligations assumed (refer to Note 3) 99,995  
Issuance of common stock for acquisition of assets (refer to Note 3) 35,588  
Dividends declared to common shareholders 2 10,530
Accrued finance costs   99
Accrued offering costs $ 1,443 $ 545
[1] Refer to Note 2 for details on the Company’s consolidated variable interest entities (“VIEs”).